[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
Clinician's Corner
August 19, 2009

Heart Failure Performance Measures and OutcomesReal or Illusory Gains

Author Affiliations

Author Affiliations: Ronald Reagan UCLA Medical Center, Los Angeles, California (Dr Fonarow); Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina (Dr Peterson).

JAMA. 2009;302(7):792-794. doi:10.1001/jama.2009.1180

Heart failure is one of the most deadly and costly conditions in the United States.1 Among Medicare beneficiaries, heart failure is the most frequent cause of hospitalization and death, with 1-year readmission and mortality rates of 65% and 35%, respectively.2 While a number of therapies and interventions have been demonstrated to improve heart failure outcomes,1 studies have consistently shown gaps, variations, and disparities in the application of these therapies in routine clinical practice.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×